FDx Advisors Inc. Boosts Holdings in Cardinal Health, Inc. (CAH)
FDx Advisors Inc. boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,508 shares of the company’s stock after buying an additional 3,172 shares during the period. FDx Advisors Inc.’s holdings in Cardinal Health were worth $2,912,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CAH. Fox Run Management L.L.C. purchased a new stake in Cardinal Health during the 2nd quarter worth approximately $234,000. Iberiabank Corp increased its stake in Cardinal Health by 4.7% during the 2nd quarter. Iberiabank Corp now owns 50,883 shares of the company’s stock worth $3,965,000 after buying an additional 2,285 shares in the last quarter. Private Trust Co. NA increased its stake in Cardinal Health by 3.8% during the 2nd quarter. Private Trust Co. NA now owns 14,259 shares of the company’s stock worth $1,111,000 after buying an additional 528 shares in the last quarter. Capital Investment Advisors LLC increased its stake in Cardinal Health by 14.1% during the 2nd quarter. Capital Investment Advisors LLC now owns 7,060 shares of the company’s stock worth $550,000 after buying an additional 873 shares in the last quarter. Finally, Appleton Partners Inc. MA increased its stake in Cardinal Health by 35.0% during the 2nd quarter. Appleton Partners Inc. MA now owns 15,763 shares of the company’s stock worth $1,228,000 after buying an additional 4,090 shares in the last quarter. Institutional investors own 87.26% of the company’s stock.
Several research analysts have recently weighed in on the company. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a report on Wednesday. Jefferies Group LLC lowered their target price on Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a report on Tuesday. BidaskClub cut Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Credit Suisse Group lowered their target price on Cardinal Health from $87.00 to $81.00 and set an “outperform” rating on the stock in a report on Thursday, August 3rd. Finally, UBS AG restated a “neutral” rating and set a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company. Cardinal Health presently has a consensus rating of “Hold” and an average price target of $74.81.
ILLEGAL ACTIVITY WARNING: “FDx Advisors Inc. Boosts Holdings in Cardinal Health, Inc. (CAH)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/fdx-advisors-inc-boosts-holdings-in-cardinal-health-inc-cah/1696102.html.
Cardinal Health, Inc. (CAH) traded down $2.01 on Friday, reaching $58.55. The company had a trading volume of 8,061,600 shares, compared to its average volume of 2,316,058. Cardinal Health, Inc. has a 12-month low of $57.54 and a 12-month high of $84.88. The firm has a market capitalization of $19,052.39, a PE ratio of 11.49, a PEG ratio of 1.75 and a beta of 0.88. The company has a quick ratio of 0.80, a current ratio of 1.06 and a debt-to-equity ratio of 1.35.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $33.48 billion. During the same period in the prior year, the firm posted $1.24 earnings per share. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. equities analysts predict that Cardinal Health, Inc. will post 4.97 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a yield of 3.16%. The ex-dividend date is Friday, December 29th. Cardinal Health’s dividend payout ratio is presently 53.78%.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.